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Chikungunya fever is a disease caused by the Chikungunya virus (CHIKV) that is
transmitted by the bite of the female of Aedes sp. mosquito. The symptoms include
fever, muscle aches, skin rash, and severe joint pains. The disease may develop into
a chronic condition and joint pain for months or years. Currently, there is no effective
antiviral treatment against CHIKV infection. Treatments based on natural compounds
have been widely studied, as many drugs were produced by using natural molecules and
their derivatives. Alpha-phellandrene (α-Phe) is a naturally occurring organic compound
that is a ligand for ruthenium, forming the organometallic complex [Ru2Cl4(p-cymene)2]
(RcP). Organometallic complexes have shown promising as candidate molecules to a
new generation of compounds that presented relevant biological properties, however,
there is a lack of knowledge concerning the anti-CHIKV activity of these complexes.
The present work evaluated the effects of the RcP and its precursors, the hydrate
ruthenium(III) chloride salt (RuCl3·xH2O) (Ru) and α-Phe, on CHIKV infection in vitro.
To this, BHK-21 cells were infected with CHIKV-nanoluciferase (CHIKV-nanoluc), a viral
construct harboring the nanoluciferase reporter gene, at the presence or absence of
the compounds for 16 h. Cytotoxicity and impact on infectivity were analyzed. The
results demonstrated that RcP exhibited a strong therapeutic potential judged by
the selective index > 40. Antiviral effects of RcP on different stages of the CHIKV
replicative cycle were investigated; the results showed that it affected early stages
of virus infection reducing virus replication by 77% at non-cytotoxic concentrations.
Further assays demonstrated the virucidal activity of the compound that completely
blocked virus infectivity. In silico molecular docking calculations suggested different
binding interactions between aromatic rings of RcP and the loop of amino acids of the
E2 envelope CHIKV glycoprotein mainly through hydrophobic interactions. Additionally,
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infrared spectroscopy spectral analysis indicated interactions of RcP with CHIKV
glycoproteins. These data suggest that RcP may act on CHIKV particles, disrupting
virus entry to the host cells. Therefore, RcP may represent a strong candidate for the
development of anti-CHIKV drugs.
Keywords: antiviral, arboviruses, Chikungunya virus, ruthenium α-Phellandrene, organometallic complex
INTRODUCTION
The Chikungunya virus (CHIKV) belongs to the genus
Alphavirus of the family Togaviridae (Chen et al., 2018; ICTV,
2019). It is a positive strand RNA virus with a genome of
approximately 12 kb (Schuffenecker et al., 2006). The icosahedral
capsid is covered by a lipid envelope derived from the host cell
membrane and contains viral glycoproteins E1 and E2 (Khan
et al., 2002; Schuffenecker et al., 2006; Thiberville et al., 2013).
CHIKV is transmitted through the bite of the female mosquito
of Aedes sp. (Vu et al., 2017) and is the causative agent of
Chikungunya fever being related to epidemics mainly in tropical
and subtropical regions (Khan et al., 2002; Paixão et al., 2018;
Stegmann-Planchard et al., 2019). CHIKV was first isolated
during an epidemic in Tanzania in 1953 (Robinsson, 1955;
Wintachai et al., 2012). In 2006, CHIKV outbreaks were reported
on several Indian Ocean islands and resulted in about 250 deaths
on the French island of La Réunion (Schuffenecker et al., 2006). In
2013, the virus was detected in the Americas with reported cases
in the Caribbean islands (Kaur and Chu, 2013). The first case in
Brazil was reported in 2014 (Carvalho et al., 2014).
Chikungunya fever presents symptoms as fever, prostration,
muscle aches, lymphopenia, and arthralgia (Cunha et al., 2017;
Paixão et al., 2018). Pain associated to arthralgia in the phalanges,
wrists, and ankles occurs in up to 98% of cases (Thiberville
et al., 2013). The infection can progress to a chronic condition in
around 70% of infected patients (de Andrade et al., 2010; Simon
et al., 2011). Muscle pain and persistent arthralgia may last for
periods ranging from months to years (Mathew et al., 2017).
Currently, there is no vaccine or specific therapy against
CHIKV infection (Yang et al., 2017; Dey et al., 2019). Treatment
of symptomatic CHIKV infections is palliative, based on the use
of non-salicylate analgesics and non-steroidal anti-inflammatory
drugs (Parashar and Cherian, 2014; Mathew et al., 2017).
Several of the currently used drugs for different pathologies
are either from natural origin or synthesized based on natural
scaffolds (Teixeira et al., 2014; da Silva-Júnior et al., 2017). Alpha-
phellandrene (α-Ph) is an organic compound of the monoterpene
class (Zhang et al., 2008), which has already been shown to
have antimicrobial, antifungal, anti-cancer, and anti-diabetic
properties (Inouye et al., 2001; Elshafie et al., 2016; Zhang et al.,
2017; Cox-Georgian et al., 2019). It is a common ligand for
ruthenium (Bennett et al., 2007), a metal belonging to the iron
group, that has shown to possess effective biological properties as
antimicrobial when complexed to other molecules (Pavan et al.,
2010). The antitumoral activity of the ruthenium α-Phellandrene
complex [Ru2Cl4(p-cymene)2] (RcP) has also been described
(Clarke et al., 1999; Habtemariam et al., 2006; Dougan and Sadler,
2007; Dyson, 2007; Vajs et al., 2015; Savić et al., 2020), however,
to the best of our knowledge, the antiviral properties of the RcP
have not been assessed yet.
Here we evaluated the antiviral activity of the RcP and
its precursors, the hydrate ruthenium(III) chloride salt
(RuCl3·xH2O) (Ru) and the α-Ph, on the CHIKV replicative
cycle. These data are the first description of the anti-CHIKV
activities of RcP complex.
MATERIALS AND METHODS
Compounds
The ruthenium and α-Phellandrene complex ([Ru2Cl4(p-
cymene)2], RcP) (Figure 1A) was synthesized as previously
described (Jensen et al., 1998). The hydrate ruthenium salt
(RuCl3.xH2O) (Ru) and alpha-phellandrene (α-Ph) used in
the synthesis of complex were purchased from Sigma-Aldrich.
The complex was dissolved in dimethyl sulfoxide (DMSO), a
coordinating solvent, and stored at −20◦C in order to decrease
the kinetic exchange of chloride and ligands. The stock solution
was stored in aliquots that were thawed only once. Dilutions of
the compounds were made immediately prior to the experiments.
For all the assays performed, control cells were treated with media
containing DMSO at the final concentration of 0.3%.
Cell Culture
BHK-21 cells (fibroblasts derived from Syrian golden hamster
kidney; ATCC CCL-10) were maintained in Dulbecco’s modified
Eagle’s media (DMEM; Sigma-Aldrich) supplemented with 100
U/mL of penicillin (Hyclone Laboratories, United States),
100 mg/mL of streptomycin (Hyclone Laboratories,
United States), 1% dilution of the stock of non-essential
amino acids (Hyclone Laboratories, United States), and 1% of
fetal bovine serum (FBS; Hyclone Laboratories, United States) in
a humidified 5% CO2 incubator at 37◦C.
Virus
The CHIKV-nanoluciferase (CHIKV-nanoluc) (Figure 1B;
Matkovic et al., 2018) used for the antiviral assays was based
on CHIKV LR2006-OPY1 strain (East/Central/South African
genotype). The cDNA plasmid of CMV-CHIKV-nanoluc
contains CMV promoter, SV40 terminator and a sequence
encoding nanoluciferase protein inserted into the region
encoding the C-terminal domain of viral nsP3 protein (Pohjala
et al., 2011; Matkovic et al., 2018). For virus rescue, 2.3 × 107
BHK-21 cells seeded in a T175 cm2 flask were transfected with
1.5 µg of CMV-CHIKV-nanoluc plasmid, using lipofectamine
3000 R© and Opti-Mem media. Forty-eight hours post transfection
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FIGURE 1 | CHIKV activity of ruthenium α-phellandrene complex (RcP). (A) RcP chemical structure. (B) Schematic representation of CHIKV-nanoluc genome.
(C) Schematic representation of infectivity assays. (D) Cells were treated with concentrations of RcP ranging from 3.9 to 500 µM and the effective concentration of
50% (EC50) and cytotoxic concentration of 50% (CC50) were determined. CHIKV replication was measured by nanoluciferase assay (indicated by ) and cellular
viability measured using an MTT assay (indicated by •). Mean values of three independent experiments each measured in quadruplicate including the standard
deviation are shown. (E) BHK-21 cells were infected with CHIKV-nanoluc at MOI 0.1 and treated with compounds at 125 µM for 16 h. Virus infectivity and cell
viability assays were performed. ***P < 0.01 was considered significant.
the supernatant containing CHIKV-nanoluc particles was
collected, clarified by filtration and stored at −80◦C. To
determine viral titer, 5 × 105 BHK-21 cells were seeded in each
well of a 6 well plate 24 h prior to the infection. Then, the cells
were infected with 10-fold serially dilutions of CHIKV-nanoluc
for 1 h at 37◦C. The inocula were removed and the cells were
washed with PBS to remove the unbound virus and incubated
with cell culture media supplemented with 1% penicillin, 1%
streptomycin, 2% FBS, and 1% carboxymethyl cellulose (CMC).
Infected cells were incubated for 2 days in a humidified 5% CO2
incubator at 37◦C, followed by fixation with 4% formaldehyde
and stained with 0.5% violet crystal. The viral plaques were
counted to determine CHIKV-nanoluc titer (Sabine, 1993).
Cell Viability Through MTT Assay
Cell viability was measured by MTT [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide] (Sigma-Aldrich) assay.
BHK-21 cells at the density of 5 × 104 were cultured in each
well of 48 well plates and treated with different concentrations
of each compound at 37◦C with 5% of CO2; DMSO was used
as vehicle control. 16 h post treatment, compound-containing
media was removed and MTT solution at 1 mg/mL was added
to each well, incubated for 1 h and replaced with 100 µL of
DMSO (dimethyl sulfoxide) to solubilize the formazan crystals.
The absorbance was measured at 560 nm on Glomax microplate
reader (Promega). Cell viability was calculated according to the
equation (T/C) × 100%, in which T and C represented the optical
density of the treated well and control groups, respectively. The
cytotoxic concentration of 50% (CC50) was calculated using
Graph Pad Prism 5.0 Software.
Antiviral Assays
To assess the antiviral activity of compounds, BHK-21 cells were
seeded at density of 5 × 104 cells per well into 48 well plates
24 h prior to the infection with CHIKV-nanoluc at a multiplicity
of infection (MOI) of 0.1 plaque forming unit/cell. Compounds
were simultaneously added to cells. Samples were harvested in
Renilla luciferase lysis buffer (Promega) at 16 h post-infection
(h.p.i.) and virus replication levels were quantified by measuring
nanoluciferase activity using the Renilla luciferase Assay System
(Promega). The effective concentration of 50% inhibition (EC50)
was calculated using Graph Pad Prism 5.0 Software. The values
of CC50 and EC50 were used to calculate the selectivity index
(SI = CC50/EC50).
To investigate which step of CHIKV replicative cycle was
targeted by the compound, BHK-21 cells at the density of 5 × 104
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cells per well were seeded in a 48 well plate 24 h prior to infection
and/or treatment for all assays. For all experiments conducted
to evaluate the effects of the compound on different stages of
replicative cycle, MOI used to infect cells was 0.1 and replication
rates were assessed measuring luminescence levels at 16 h.p.i.
To evaluate if the compound possesses protective activity to the
host cells, cells were treated for 1 h with the compound before
infection, extensively washed with PBS (phosphate buffered
saline) to remove compound and then infected with CHIKV-
nanoluc. The effect on the entry steps was analyzed by incubating
virus and compound simultaneously with BHK-21 cells for
1 h. Then, cells were washed for the removal of the inoculum
and replaced by fresh media. To investigate the activity of the
compound on post-entry stages of viral replicative cycle, cells
were infected with CHIKV for 1 h, washed extensively with
PBS to remove unbound virus after which media containing
compound was added.
The virucidal activity of the compound was assessed by
previously incubating virus and compound for 1 h at 37◦C
and then adding the inoculum to the cells for an extra 1 h.
The inoculum was removed and replaced by fresh media. To
evaluate the attachment step, the cells were treated with virus and
compound for 1 h at 4◦C, and then were washed with PBS and
replaced by media. For the uncoating step, virus and compound
were incubated with cells for 1 h at 4◦C followed by 30 min at
37◦C, and then washed and replaced by media.
Quantum Mechanics and Molecular
Docking Studies
The RcP molecular structure was optimized using the ORCA
4.2.1 (Neese, 2018) program. B3LYP density functional model
(comprising Slater local exchange, the Becke non-local exchange,
the Vosco-Wilk-Nusair local correlation functional and the Lee-
Yang-Parr non-local correlation functional) along with basis
set LANL2DZ (Los Alamos National Laboratory 2-double-ζ),
which also incorporates an “Effective Core Potential,” were
used for calculations (Cao and Ren, 2011). Absence of negative
frequencies in vibrational analysis of complexes confirmed
that the optimized geometry was the lowest energy structure.
Docking studies were performed using autodock4.2 (Morris et al.,
2009) with RcP ligand. The crystal structure of the mature
envelope glycoprotein complex (furin cleavage) of CHIKV used
as target protein (PDB code: 3N42) was obtained from the
Protein Data Bank. The dock procedures were performed using
the AutoDockTools 1.5.6 interface along with autogrid4 and
autodock4 (AD4). To prepare the ligand to molecular docking,
the AutoDockTools 1.5.6 (Sanner, 1999) added Gasteiger charges
and converted the target crystal structure in a format required
for AD4. The Lamarckian genetic algorithm in Autodock
were: population (150 individuals); maximum energy evaluations
(25,000,000); maximum generations (27,000); one individual
surviving into next generation; genetic algorithm docking runs
(150); and a ranked cluster analysis was performed using an RMS
tolerance of 2.0 Å on each docking calculation. The grid map
used was 118 × 112 × 110 points, centers of grid: x = −18.369;
y = 13.506; z = −22.667 with a grid space of 0.375 Å. Ligand
interactions were analyzed using the Discovery Studio Visualizer
program (BIOVIA, 2020).
Infrared Spectroscopy Spectral Data
Analysis
A micro-attenuated total reflectance (ATR) device coupled to
an ATR-FTIR spectrophotometer Vertex 70 (Bruker Optics,
Reinstetten, Germany) was used to record the infrared fingerprint
between 1,800 cm−1 and 400 cm−1region. The internal-reflection
element of ATR unit is blended by a diamond disk. The infrared
beam is reflected at the interface toward the sample in the
ATR-crystal. The background of the air spectrum was removed
in all ATR-FTIR dataset. One microliter of each sample was
dried using airflow on ATR-crystal for 2.5 min. Then, sample
spectra were recorded in triplicate. All samples were acquired
with 4 cm−1 of resolution and 32 scans were performed to each
sample analysis. The mean spectra were normalized by the vector
method and adjusted to rubber band baseline correction. The
original data were plotted in the Origin Pro 9.0 (OriginLab,
Northampton, MA, United States) software to perform the
second derivative analysis, which was obtained by applying
Savitzky-Golay algorithm with polynomial order 5 and 20 points
of the window. The height of valley indicated the intensity of
functional group evaluated (Dinache et al., 2020).
Statistical Analysis
Individual experiments were performed in triplicate and all assays
were performed a minimum of three times in order to confirm
the reproducibility of the results. Differences between means of
readings were compared using analysis of variance (one-way or
two-way ANOVA) or Student’s t-test using Graph Pad Prism 5.0
software (Graph Pad Software). P-values < 0.01 were considered
to be statistically significant.
RESULTS
Ruthenium and Alpha-Phellandrene
Complex (RcP) Inhibits CHIKV Infection
in vitro
Since ruthenium complexes were shown to possess antimicrobial
properties (Pavan et al., 2010), we aimed to investigate the anti-
CHIKV activity of the RcP (Figure 1A) by using a recombinant
CHIKV that expresses the nanoluciferase reporter (CHIKV-
nanoluc) (Figure 1B).
To assess the effect of RcP on cell viability and virus infection,
we therefore performed a dose response assay to determine
the effective concentration of 50% (EC50) and the cytotoxicity
concentration of 50% (CC50) values for RcP. BHK-21 cells
were infected with CHIKV-nanoluc and treated with RcP at
concentrations ranging from 3.9 to 500 µM and viral replication
efficiency was evaluated measuring activities of nanoluciferase
reporter at 16 h.p.i. (Figure 1C). In parallel, cell viability was
measured by MTT assay. The results showed that RcP was able
to completely block the virus replication while the minimum
cell viability was 84% of that of DMSO treated control cells
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(Figure 1D). By the use of this range of concentrations, it
was determined that the RcP complex has an EC50 of 32 µM,
CC50 > 1,300 µM and Selective Index (SI) of 43.
Since the complex was shown to be strongly active against
CHIKV at a concentration of 125 µM with no cytotoxicity, we
also evaluated effects of its precursors, the hydrate ruthenium
salt RuCl3.xH2O (Ru) and the α-Phellandrene (α-Ph), at this
concentration on cell viability and viral replication. Cells were
infected with CHIKV-nanoluc at the MOI of 0.1 and treated with
RcP, Ru or α-Ph at 125 µM. The efficiency of viral replication
and cell viability were evaluated after 16 h by luminescence and
MTT assays, respectively (Figure 1C). The results showed that
RcP significantly (p < 0.01) inhibited 91% of CHIKV replication
and presented no toxicity to cells (Figure 1E). Albeit, Ru and
α-Ph decreased cell viability and/or presented reduced antiviral
activity compared to the complex (p < 0.01) (Figure 1E). This
data demonstrated that RcP exhibited the best therapeutic index
(favorable ratio of cytotoxicity to antiviral potency) and was
therefore selected for further analysis.
RcP Strongly Inhibits CHIKV Entry to the
Host Cells
The antiviral activity of the RcP at 125 µM on different stages of
CHIKV replication was analyzed by infecting cells with CHIKV-
nanoluc at the MOI of 0.1 and measuring luminescence levels
16 h.p.i., for all performed assays.
First, BHK-21 cells were pretreated with RcP for 1 h at
37◦C, washed with PBS to completely remove the compound
and then were infected with CHIKV-nanoluc (Figure 2A). In
this experiment, the RcP demonstrated a modest yet significant
(p < 0.01) reduction of 23% of luminescence levels (Figure 2A).
To evaluate the effect of RcP on the early stages of infection,
virus and RcP were simultaneously added to BHK-21 cells,
treatment lasted for 1 h, then washed with PBS and was followed
by incubation in the absence of compound (Figure 2B). Under
these conditions, treatment with RcP significantly (p < 0.01) and
prominently (by ∼77%) reduced virus replication indicating that
RcP inhibits virus entry to the host cells (Figure 2B).
In order to reveal whether RcP also inhibited post-entry
steps, the cells were first infected with CHIKV-nanoluc for
1 h at 37◦C, washed to remove unbound virus and then
incubated with compound containing media (Figure 2C). RcP
also demonstrated a modest yet significant (p < 0.01) reduction
of 21% of luminescence levels when the treatment was performed
after virus entry to the cells (Figure 2C). However, it cannot be
excluded that RcP inhibited spread of progeny virus from infected
cells to non-infected cells instead of post-entry stages. Altogether,
our data clearly suggest that the predominant antiviral activity of
RcP is related to its ability to inhibit the entry stage of the virus
lifecycle. Therefore, the activity of RcP on CHIKV entry to the
cells was further evaluated.
First, supernatant containing CHIKV-nanoluc was incubated
with RcP for 1 h at 37◦C, prior to the infection of cells, to
investigate if the compound possesses a virucidal effect. The
inoculum of virus and RcP was transferred to naïve BHK-21 cells
and incubated for 1 h. Cells were washed to remove the inoculum
and replaced with fresh media (Figure 3A). This assay revealed
a very strong significant virucidal activity of RcP resulting in the
complete blockage of virus infection (p < 0.01) (Figure 3A).
Next, the effect of RcP on virus attachment was analyzed. For
this, cells were incubated with virus in the presence of RcP at
4◦C for 1 h; upon these conditions, virus is able to attach to
cell membrane receptor, but not to enter the host cells. Then,
cells were washed and fresh media was added (Figure 3B).
Data obtained from this assay showed that RcP reduced 90% of
virus replication (p < 0.01), indicating that RcP reduced virus
binding to the host cells (Figure 3B). Finally, the experiment
was repeated allowing incubation with virus and compound for
extra 30 min at 37◦C after the attachment at 4◦C. This assay
was designed to include entry and uncoating steps (Tumkosit
et al., 2019). Cells were washed and a fresh media was added
(Figure 3C). The results demonstrated that under this protocol of
treatment, the complex inhibited up to 55% of the viral infectivity
(p < 0.01) (Figure 3C). Collectively, these data demonstrated
that RcP was able to abrogate the early stages of virus entry to
the host cells (Figure 3). The strongest effect was observed in
virucidal experiments; effects on other stages of infection may be
consequences of this activities. This suggests that an anti-CHIKV
mechanism of action for this complex might be related to a direct
action on the virus structure, resulting in the virions inactivation
and/or inability to bind to cellular receptors.
Potential Mechanisms of Action of RcP
Based on the results that showed RcP interfering with CHIKV
entry to the host cells, molecular docking calculations were
performed in order to investigate possible binding mode
and interactions between RcP and CHIKV glycoproteins. The
in silico analysis demonstrated that RcP was predicted to
dock between two loops of the chain B of the E2 envelope
glycoprotein (Figure 4), and the highest docking score presented
a binding energy of −7.68 kcal mol−1 and a inhibition
constant (Ki) of 2.35 µM, showing that this compound might
interact with CHIKV E2 (Chain B). The molecular docking
study also suggested that RcP showed different interactions
between its aromatic rings and the loop of amino acids of
the E2 glycoprotein, mainly through hydrophobic interactions
and one pi-pi stacking (Figure 5). However, the ruthenium
and the chloride atoms did not participate in the principal
docking pose, which accessed 9 amino acids (GLU139, LYS140,
ILE136, ARG104, ASP43, ARG144, PRO106, VAL135, and
ASP132) through these hydrophobic interactions (Figure 5).
The amino acid LYS140 hydrophobically interacted with the
two α-Ph ligands through its methyl group (Figure 5). The
pi-pi stacking only occurred with one aromatic ring of the
α-Ph and the PHE141 amino acid (Figure 5A). Therefore, the
ruthenium—phenyl interaction was of fundamental importance
for complex stabilization and, consequently, the simultaneous
interaction between the two alpha-phellandrene with the two
loops of chain B.
To further investigate the interaction between RcP and
CHIKV virions, ATR-FTIR spectroscopy spectral analysis was
performed. The vibrational modes detected in CHIKV virion
and/or RcP are shown in Table 1. The representative infrared
Frontiers in Microbiology | www.frontiersin.org 5 December 2020 | Volume 11 | Article 608924
fmicb-11-608924 December 9, 2020 Time: 18:33 # 6
Oliveira et al. Organometallic Complex Impairs CHIKV Infection
FIGURE 2 | Time of addition analysis reveals that RcP mainly inhibits entry step of CHIKV infection. (A) Schematic presentation and results of pre-treatment
experiment. (B) Schematic presentation and results of experiment analyzing effect of RcP on early stages of infection. (C) Schematic presentation and results of
post-treatment experiment. For all assays, CHIKV replication was analyzed by measuring of nanoluc activity at 16 h.p.i. Mean values of a minimum of three
independent experiments each measured in triplicate. ***P < 0.01 was considered significant.
FIGURE 3 | RcP exhibits strong virucidal activity. (A) Schematic presentation and results of virucidal assay. (B) Schematic presentation and results of attachment
inhibition assay. (C) Schematic presentation and results of uncoating inhibition assay. For all assays, CHIKV replication was measured by nanoluc activity at 16 h.p.i.
Mean values of a minimum of three independent experiments each measured in triplicate ***P < 0.01 was considered significant.
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FIGURE 4 | The CHIKV glycoprotein complexed with RcP. The E3 envelope (chain A) is presented in blue, the E2 envelope (chain B) in red and the E1 envelope
(chain F) in gray. The NewCartoon representation was used for the glycoprotein and the licorice representation used for the ligand.
spectra of RcP, CHIKV virions, or RcP plus CHIKV virions,
which contains different biochemical functional groups such as
lipids, proteins, glycoproteins and nucleic acid, are represented
in Figure 6. We were particularly interested in confirming the
interaction of RcP with CHIKV virions which can be represented
by the molecular infrared analysis. The representative infrared
spectra of the second derivative analysis of RcP, CHIKV virions,
or RcP plus CHIKV virions are displayed in Figure 7A. In the
second derivative analysis, which the value heights indicated the
intensity of each functional group, a reduction in intensity of
Amide II [ν (N–H), ν (C–N)] at 1,540 cm−1 in RcP plus CHIKV
virions suggests interaction of RcP with proteins of CHIKV
virions (Figure 7B). The binding interaction was also revealed
by spectral shifting of the 1,013–1,005 cm−1, which indicates
interaction with vs. (CO-O-C) presents in glycoprotein derived
from RcP and/or CHIKV virions (Figure 7C). Additionally, it
was observed the decrease in intensity of 724, 679, 645, and
609 cm−1 in RcP plus CHIKV, which indicates interaction of C-H
rocking of CH2 and S-O bending, reinforcing interaction. The
binding interaction was additionally confirmed by the increase in
intensity of 704, 652, and 632 cm−1 in RcP plus CHIKV virions,
which indicates formation in the presence of OH out-of-plane
bend (Figure 7D).
DISCUSSION
Chikungunya virus (CHIKV) has recently attracted worldwide
public health attention due to massive outbreaks (Gould
et al., 2017) and its ability to cause highly debilitating chronic
disease that may persist for months or even years (Cunha
and Trinta, 2017). CHIKV was first described in the 1950s
(Robinsson, 1955), however, there are no approved therapeutics
or vaccines against this infection (Mathew et al., 2017;
Stegmann-Planchard et al., 2019). Thus, the search for
new molecules with anti-CHIKV activity is critical in this
public health issue.
In this study, the anti-CHIKV activity of the
ruthenium and alpha-phellandrene complex (RcP)
was investigated. For years, RcP has been showing
potential activity against cancer (Dougan and Sadler,
2007; Dyson, 2007). However, its activity against viruses
remains unknown.
Our results showed that RcP significantly reduced virus
entry to host cells at non-toxic concentrations, and therefore,
the effect of this complex was further evaluated on the early
stages of CHIKV infection. RcP demonstrated a moderate yet
significant activity on the virus uncoating and strong action on
inhibiting virus attachment or as a virucide, being the latest
the strongest activity of RcP. Several studies demonstrated the
biological activities of this complex (Habtemariam et al., 2006;
Savić et al., 2020), however, to the best of our knowledge there is
no description of its antiviral activity.
The virucidal effect was the strongest activity observed for RcP
which might suggest that an anti-CHIKV mechanism of action
for this complex might be related to a direct action on the viral
particle envelope. Previous studies have shown that the virucidal
effect of several compounds is closely related to an action on
the virus envelope (Tang et al., 1990; Schuhmacher et al., 2003;
Carravilla et al., 2017; Kong et al., 2019; Russo et al., 2019). This
suggests the existence of interactions between CHIKV envelope
glycoproteins and RcP. Based on these data, molecular coupling
calculations were performed to investigate the possible binding
mode and interactions between RcP and CHIKV glycoproteins.
Our results indicated that RcP can bind to a location between
two loops of the E2 envelope glycoprotein B chain. Studies have
already shown that the glycoprotein E2 is responsible for the
binding of the virus to the cell receptor (Moller-tank et al., 2013;
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FIGURE 5 | 2D interactions diagrams (DS Visualizer) between the loop residues of the E2 glycoprotein and RcP. (A) Interactions between E2 envelope glycoprotein
and ring 1. (B) Interactions between E2 envelope glycoprotein and ring 2. Non-polar hydrogen atoms were omitted for clarity.
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TABLE 1 | Identification of functional group and molecular source of respective
vibrational modes in ruthenium α-phellandrene complex (RcP) plus CHIKV sample.
Vibrational
mode (cm1)
Proposed functional group Molecular source
1,540 Amide II [ν (N–H), ν (C–N)] Protein
1,013 vs. (CO-O-C) Glycoprotein/Carbohydrates






















Assignments of main wavenumbers of sample ATR-FTIR spectra. ν, stretching
vibrations; δ, bending vibrations; s, symmetric vibrations and as, asymmetric
vibrations.
Fongsaran et al., 2014; Silva et al., 2014). Rashad and Keller
(2013) showed that when small molecules bind to a region
between the two loops of the E2 B chain, the movement of the
glycoprotein domains can be modified and prevent the virus
from entering the cell (Rashad and Keller, 2013). We suggest
that RcP may be binding to such a site and preventing the
virus from binding to the cell. Furthermore, through molecular
interactions observed by infrared spectroscopy, we can suggest
that RcP may interfere with CHIKV glycoprotein and lipid
sites, corroborating that there is an interaction between the viral
envelope and RcP.
FTIR spectroscopy has been used for detection and
quantification of viral pathogens, and could be also required for
molecular responses to viral infections in tissue, cell or biofluids
(Lee-Montiel et al., 2011). Recently, this tool was also used to
identify molecular structures in viral components under changes
in pH and to investigate molecular modification of viruses
in the presence of antiviral compounds (Lai and Freed, 2015;
Gamage et al., 2018). In this context, the interactions between
RcP and CHIKV virions could be suggested based on changes
observed in intensity of vibrational mode at 1,540 cm−1, which
indicate the association of RcP with Amide II functional groups
present in viral proteins. The shift in a specific vibrational mode
can also indicates interaction between molecules (Popova and
Hincha, 2003). It was revealed in our results by infrared spectral
shifting of the 1,013–1,005 cm−1, indicating an interaction of
CO-O-C presents in glycoprotein of CHIKV virions. Therefore,
the assumption of RcP interaction with the amino acids of the
CHIKV glycoprotein E2 by the molecular docking analysis
could be reinforced by infrared spectroscopy analysis. The
reduction in the intensity of 724, 679, 645, and 609 cm−1 in
RcP plus CHIKV virions compared with only RcP suggests
interaction in C-H rocking and S-O bending present in RcP.
Thus, ATR-FTIR represented a powerful, sustainable, fast,
cost-effective and label-free platform to the understanding
of the interaction of CHIKV glycoproteins with RcP and,
consequently, providing insights on the mode of action of this
organometallic complex.
In summary, we showed that RcP was able to strongly
inhibit CHIKV infectivity, acting on the early stages of virus
FIGURE 6 | Representative infrared average spectrum of RcP. CHIKV virions, RcP and RcP + CHIKV virions, which contains several molecular functional groups in
lipids, proteins, glycoproteins and nucleic acid.
Frontiers in Microbiology | www.frontiersin.org 9 December 2020 | Volume 11 | Article 608924
fmicb-11-608924 December 9, 2020 Time: 18:33 # 10
Oliveira et al. Organometallic Complex Impairs CHIKV Infection
FIGURE 7 | Representative infrared average spectrum of second derivative. (A) Analysis from CHIKV virion, RcP and RcP + CHIKV virion. (B–D) Second derivative
analysis, which the value heights indicate the intensity of each functional group.
infection, mainly as a virucidal inhibitor. To the best of our
knowledge, this is the first description of the antiviral activity
of RcP against CHIKV. This data may be useful for the
development of future antivirals against CHIKV that will provide
a relevant advance to the public health in the combat of
Chikungunya fever.
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